These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7591903)

  • 21. Is a Technetium-99m Macroaggregated Albumin Scan Essential in the Workup for Selective Internal Radiation Therapy with Yttrium-90? An Analysis of 532 Patients.
    Sancho L; Rodriguez-Fraile M; Bilbao JI; Beorlegui Arteta C; Iñarrairaegui M; Moran V; Sangro B
    J Vasc Interv Radiol; 2017 Nov; 28(11):1536-1542. PubMed ID: 28916345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of scatter correction for the assessment of lung shunting prior to yttrium-90 radioembolization therapy.
    O'Doherty J; Scuffham J; Hinton P
    Nucl Med Commun; 2011 Jul; 32(7):628-34. PubMed ID: 21540757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres.
    Ulrich G; Dudeck O; Furth C; Ruf J; Grosser OS; Adolf D; Stiebler M; Ricke J; Amthauer H
    J Nucl Med; 2013 Apr; 54(4):516-22. PubMed ID: 23447653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment.
    Ahmadzadehfar H; Sabet A; Biermann K; Muckle M; Brockmann H; Kuhl C; Wilhelm K; Biersack HJ; Ezziddin S
    J Nucl Med; 2010 Aug; 51(8):1206-12. PubMed ID: 20660379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting.
    Gaba RC; Zivin SP; Dikopf MS; Parvinian A; Casadaban LC; Lu Y; Bui JT
    Radiology; 2014 May; 271(2):602-12. PubMed ID: 24533871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations.
    Strigari L; Sciuto R; Rea S; Carpanese L; Pizzi G; Soriani A; Iaccarino G; Benassi M; Ettorre GM; Maini CL
    J Nucl Med; 2010 Sep; 51(9):1377-85. PubMed ID: 20720056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profound transient thrombocytopenia associated with 90Yttrium microsphere therapy for inoperable hepatoma.
    Yang CW; Yen HH; Su WW; Chen YY; Soon MS
    South Med J; 2010 Dec; 103(12):1264-8. PubMed ID: 21037524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres.
    Prince JF; van Rooij R; Bol GH; de Jong HW; van den Bosch MA; Lam MG
    J Nucl Med; 2015 Jun; 56(6):817-23. PubMed ID: 25931477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yttrium-90 (Y-90) Resin Microsphere Therapy for Patients with Unresectable Hepatocellular Carcinoma: a Single-Center Experience.
    İnce S; Karaman B; Alagoz E; Karadurmuş N; Şan H; Erçin CN; Arslan N
    J Gastrointest Cancer; 2017 Sep; 48(3):281. PubMed ID: 28634669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Underlying liver disease influences volumetric changes in the spared hemiliver after selective internal radiation therapy with 90Y in patients with hepatocellular carcinoma.
    Teo JY; Goh BK; Cheah FK; Allen JC; Lo RH; Ng DC; Goh AS; Khor AY; Sim HS; Ng JJ; Chow PK
    J Dig Dis; 2014 Aug; 15(8):444-50. PubMed ID: 24828952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.
    Ho S; Lau WY; Leung TW; Chan M; Ngar YK; Johnson PJ; Li AK
    Eur J Nucl Med; 1996 Aug; 23(8):947-52. PubMed ID: 8753684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin.
    Leung WT; Lau WY; Ho SK; Chan M; Leung NW; Lin J; Metreweli C; Johnson PJ; Li AK
    J Nucl Med; 1994 Jan; 35(1):70-3. PubMed ID: 8271063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin.
    Ho S; Lau WY; Leung TW; Chan M; Chan KW; Lee WY; Johnson PJ; Li AK
    Br J Radiol; 1997 Aug; 70(836):823-8. PubMed ID: 9486047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of High Hepatopulmonary Shunting in Patients Undergoing Hepatic Radioembolization.
    Ward TJ; Tamrazi A; Lam MG; Louie JD; Kao PN; Shah RP; Kadoch MA; Sze DY
    J Vasc Interv Radiol; 2015 Dec; 26(12):1751-60. PubMed ID: 26525118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-dimensional personalized Monte Carlo dosimetry in 90Y resin microspheres therapy of hepatic metastases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization.
    Petitguillaume A; Bernardini M; Hadid L; de Labriolle-Vaylet C; Franck D; Desbrée A
    J Nucl Med; 2014 Mar; 55(3):405-13. PubMed ID: 24504053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastatic liver carcinoma.
    Wong CY; Savin M; Sherpa KM; Qing F; Campbell J; Gates VL; Lewandowski RJ; Cheng V; Thie J; Fink-Bennett D; Nagle C; Salem R
    Cancer Biother Radiopharm; 2006 Aug; 21(4):305-13. PubMed ID: 16999596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization.
    Olorunsola OG; Kohi MP; Behr SC; Kolli PK; Taylor AG; Tong RT; LaBerge JM; Kerlan RK; Fidelman N
    J Vasc Interv Radiol; 2015 Oct; 26(10):1472-8. PubMed ID: 26296737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extra-hepatic embolisation of Y-90 microspheres from selective internal radiation therapy (SIRT) of the liver.
    Thamboo Tp; Tan KB; Wang SC; Salto-Tellez M
    Pathology; 2003 Aug; 35(4):351-3. PubMed ID: 12959774
    [No Abstract]   [Full Text] [Related]  

  • 40. 90Yttrium microspheres for nonresectable liver cancer: the University of Connecticut Health Center experience.
    Rowe BP; Weiner R; Foster J; Dowsett R
    Conn Med; 2007 Oct; 71(9):523-8. PubMed ID: 17966721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.